4D Molecular Therapeutics

Free public records show 4D Molecular Therapeutics in 2 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by 4D Molecular Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on 4D Molecular Therapeutics

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Stock listing
NASDAQ: FDMT
Type
Medicines

Source: SEC EDGAR, Company filings, CIK 1650648. Retrieved 13 Nov 2026.

Trials over time

Studies 4D Molecular Therapeutics leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with 4D Molecular Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show 4D Molecular Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Healthcare Topics

The topics of the markets 4D Molecular Therapeutics is in.

All healthcare topics

Search all reports for 4D Molecular Therapeutics All companies